» Articles » PMID: 16266700

New Achievements and Pharmacotherapeutic Approaches in the Treatment of Alcohol Dependence

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 2005 Nov 4
PMID 16266700
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The treatment of alcohol dependence mainly consists of psychological, social, and pharmacotherapeutic interventions aiming to reduce physical withdrawal, craving, and alcohol relapse. During the last years, it has become increasingly clear that adjuvant pharmacotherapy is efficacious especially in rehabilitation programs for alcohol dependent patients. The development of alcohol dependence seems to involve adaptive changes in amino acid neurotransmitter systems, stimulation of dopamine and opioid peptide systems, and changes in serotonergic activity. Disulfiram, naltrexone and acamprosate are approved treatments for the management of abstinence maintenance treatment. New compounds are under investigation. This review discusses the neurobiological basis of alcohol addiction, pharmacological targets for relapse prevention treatment and pre-clinical and clinical results with the most promising drugs.

Citing Articles

Protective effect of Terminalia arjuna against alcohol induced oxidative damage of rat erythrocyte membranes.

Hebbani A, Vaddi D, Dd P, NCh V J Ayurveda Integr Med. 2021; 12(2):330-339.

PMID: 33731264 PMC: 8186002. DOI: 10.1016/j.jaim.2021.02.001.


Voluntary alcohol consumption is increased in female, but not male, oxytocin receptor knockout mice.

Rodriguez K, Smith B, Caldwell H Brain Behav. 2020; 10(9):e01749.

PMID: 32666677 PMC: 7507036. DOI: 10.1002/brb3.1749.


Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers.

Fitzgerald N, Angus K, Elders A, de Andrade M, Raistrick D, Heather N Addiction. 2016; 111(8):1477-87.

PMID: 27262594 PMC: 5089629. DOI: 10.1111/add.13438.


Different phenotypic and genotypic presentations in alcohol dependence: age at onset matters.

Chen Y, Prescott C, Walsh D, Patterson D, Riley B, Kendler K J Stud Alcohol Drugs. 2011; 72(5):752-62.

PMID: 21906503 PMC: 3174022. DOI: 10.15288/jsad.2011.72.752.


Status of disulfiram in present day alcoholic deaddiction therapy.

Palatty P, Saldanha E Indian J Psychiatry. 2011; 53(1):25-9.

PMID: 21431004 PMC: 3056183. DOI: 10.4103/0019-5545.75557.